Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Suman Malempati, MD
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
139 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sydney Children'S Hospital
Randwick, New South Wales, Australia
- the Children'S Hospital at Westmead
Westmead, New South Wales, Australia
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Royal Children'S Hospital-Brisbane
Herston, Queensland, Australia
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- British Columbia Children'S Hospital
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Chedoke-Mcmaster Hospitals
Hamilton, Ontario, Canada
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Children'S Hospital of Eastern Ontario
Ottawa, Ontario, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
- the Montreal Children'S Hospital of the Muhc
Montreal, Quebec, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Canada
- Starship Children'S Hospital
Grafton, Auckland, New Zealand
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Phoenix Childrens Hospital
Phoenix, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Southern California Permanente Medical Group
Downey, California, United States
- Miller Children'S and Women'S Hospital Long Beach
Long Beach, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- David Geffen School of Medicine at Ucla
Los Angeles, California, United States
- Mattel Children'S Hospital Ucla
Los Angeles, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Children'S Hospital and Research Center at Oakland
Oakland, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Childrens Hospital of Orange County
Orange, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke'S Medical Center
Denver, Colorado, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2010
- Primary completion
- 30 Jun 2016
- Completion
- 30 Jun 2016
- Last update posted
- 29 Aug 2017
- Registered enrollment
- 175
- Registry id
- NCT01055314
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.